Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B SHANGHAI, Nov. 20, 2024 /PRNewswire/ — Epigenic Therapeutics, a leading biotechnology company… CISION PRNewswireNovember 20, 2024
Warringtonfire Australia Rebrands to Jensen Hughes, Strengthening Global Fire Safety Engineering, Fire Testing and Fire Assessment Services Integration expands Jensen Hughes’ fire testing, fire assessment and fire safety engineering… CISION PRNewswireNovember 20, 2024
Moatable Reports Third Quarter 2024 Financial Results PHOENIX, Nov. 20, 2024 /PRNewswire/ — Moatable, Inc. (OTC: MTBLY) ("Moatable" or… CISION PRNewswireNovember 20, 2024
Turpan's Wind Power Capacity Achieves New Milestone with Over 4 Billion kWh Generated in 2024 TURPAN, China, Nov. 20, 2024 /PRNewswire/ – As of November 18, 2024,… CISION PRNewswireNovember 20, 2024
Press ReleaseRichard Flanagan's Question 7 wins The Baillie Gifford Prize for Non-Fiction 2024 LONDON, Nov. 20, 2024 /PRNewswire/ — Question 7 by Richard Flanagan is… CISION PRNewswireNovember 20, 2024
Press ReleaseRichard Flanagan's Question 7 wins The Baillie Gifford Prize for Non-Fiction 2024 LONDON, Nov. 20, 2024 /PRNewswire/ — Question 7 by Richard Flanagan is… CISION PRNewswireNovember 20, 2024
ZTO Reports Third Quarter 2024 Unaudited Financial Results Robust Profitability amidst Consumption Mix-shiftAdjusted Net Income Grew 2.0% to RMB2.4 BillionParcel… CISION PRNewswireNovember 20, 2024
Blackbaud Institute Releases New Research on Charitable Support Trends Across Generations in Australia and New Zealand Financial Donations Lead as Most Impactful Support Method Across Generations, but Volunteering… CISION PRNewswireNovember 20, 2024
